SU
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS · NSE
₹1,850.10 -0.79% (-₹14.80)
1M -3.97%
Market Cap ₹4.48T
P/E Ratio 37.03x
Div. Yield 0.27%
ROE 14.96%
Bulios Fair Price
₹1,283
30.7% downside
Trenutna cena
₹1,850
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SUNPHARMA.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
9 /100
Expensive P/FCF 187.23x
P/S 7.48x
P/B 5.34x
Growth
77 /100
Growing Rev. growth 10.03%
FCF growth 47.61%
Book val. growth 14.28%
Profitability
77 /100
Strong Net margin 20.19%
Op. margin 22.93%
FCF margin 3.99%
Quality
70 /100
Excellent ROE 14.96%
ROA N/A
Asset turnover N/A
Debt
100 /100
Low Int. coverage 43.22x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
75 /100
Stable Rev. volatility 1.45%
EPS volatility 5.12%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SUNPHARMA.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kirti Ganorkar
Employees
47,000
Headquarters
Mumbai
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report